BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34504198)

  • 1. An investigation into the avoidability of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
    Danjuma MI; Naseralallah LMA; AbouJabal B; Mohamed MF; Abubeker IY; Jabbar LA; Elzouki A
    Sci Rep; 2021 Sep; 11(1):17887. PubMed ID: 34504198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avoidability of drug-induced liver injury (DILI) in an elderly hospital cohort with cases assessed for causality by the updated RUCAM score.
    Danjuma MI; Almasri H; Alshokri S; Khir FK; Elmalik A; Battikh NG; Abdallah IMH; Elshafei M; Fatima H; Mohamed MFH; Maghoub Y; Hussain T; Kamal I; Anwer Z; Bidmos MA; Elzouki AN
    BMC Geriatr; 2020 Sep; 20(1):346. PubMed ID: 32928134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation into the avoidability of adverse drug reactions using the LAAT and modified Hallas tools.
    Danjuma MI; Shokri SA; Abubeker IY; Malik AE; Abdallah IMH; Shafei MNE; Fatima H; Mahmoud M; Hussain T; Maghoub Y; Sajid J; Zouki ANE
    Medicine (Baltimore); 2020 Jan; 99(1):e18569. PubMed ID: 31895800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RegiSCAR DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) Validation Scoring System and Japanese Consensus Group Criteria for Atypical Drug-Induced Hypersensitivity Syndrome (DiHS): A Comparative Analysis.
    Sasidharanpillai S; Ajithkumar K; Jishna P; Khader A; Anagha KV; Binitha MP; Chathoth AT
    Indian Dermatol Online J; 2022; 13(1):40-45. PubMed ID: 35198466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel targeted inhibition of the IL-5 axis for drug reaction with eosinophilia and systemic symptoms syndrome.
    Rubin L; Talmon A; Ribak Y; Kessler A; Martin Y; Haran TK; Shamriz O; Adini I; Tal Y
    Front Immunol; 2023; 14():1134178. PubMed ID: 37187735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a study of 25 patients in Korea.
    Lee JY; Lee SY; Hahm JE; Ha JW; Kim CW; Kim SS
    Int J Dermatol; 2017 Sep; 56(9):944-951. PubMed ID: 28718873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric drug reaction with eosinophilia and systemic symptoms: A 12-year retrospective study in a tertiary center.
    Chatproedprai S; Tiasiri N; Chantawarangkul K; Wananukul S
    J Dermatol; 2024 Apr; 51(4):509-517. PubMed ID: 38214543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand.
    Hiransuthikul A; Rattananupong T; Klaewsongkram J; Rerknimitr P; Pongprutthipan M; Ruxrungtham K
    Allergol Int; 2016 Oct; 65(4):432-438. PubMed ID: 27134114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening the European pharmacovigilance database for reports of clozapine-related DRESS syndrome: 47 novel cases.
    de Filippis R; Kane JM; Kuzo N; Spina E; De Sarro G; de Leon J; De Fazio P; Schoretsanitis G
    Eur Neuropsychopharmacol; 2022 Jul; 60():25-37. PubMed ID: 35635994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug reaction with eosinophilia and systemic symptoms: A single center descriptive observational study.
    Sandhu S; Neema S; Vashisht D; Venugopal R; Sengupta P; Radhakrishnan S
    Dermatol Ther; 2021 Jan; 34(1):e14670. PubMed ID: 33314590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The determination of causality of drug induced liver injury in patients with COVID-19 clinical syndrome.
    Naseralallah LM; Aboujabal BA; Geryo NM; Al Boinin A; Al Hattab F; Akbar R; Umer W; Abdul Jabbar L; Danjuma MI
    PLoS One; 2022; 17(9):e0268705. PubMed ID: 36048762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cicatrizing Conjunctivitis in a Patient Diagnosed With Drug Reaction With Eosinophilia and Systemic Symptoms/Drug-Induced Hypersensitivity Syndrome but With Features of Stevens-Johnson Syndrome.
    Bohm KJ; Ciralsky JB; Harp JL; Bajaj S; Sippel KC
    Cornea; 2016 Jun; 35(6):888-91. PubMed ID: 27078005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difficult clinical management of antituberculosis DRESS syndrome complicated by MRSA infection: A case report.
    Wang L; Li LF
    Medicine (Baltimore); 2017 Mar; 96(11):e6346. PubMed ID: 28296768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of systemic to topical steroids switch on the outcome of drug reaction with eosinophilia and systemic symptoms (DRESS): A monocenter retrospective study of 20 cases.
    Brin C; Bernigaud C; Hua C; Duong TA; Gaudin O; Colin A; de Prost N; Wolkenstein P; Chosidow O; Ingen-Housz-Oro S
    Ann Dermatol Venereol; 2021 Sep; 148(3):168-171. PubMed ID: 33858692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral rashes mimicking drug reaction with eosinophilia and systemic symptoms syndrome in children after β-lactams intake: a diagnostic challenge.
    Dondi A; Parladori R; Mori F; Liccioli G; Bassi A; Lanari M; Patrizi A; Neri I
    Eur J Pediatr; 2021 Jul; 180(7):2327-2332. PubMed ID: 33686529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR).
    Kano Y; Tohyama M; Aihara M; Matsukura S; Watanabe H; Sueki H; Iijima M; Morita E; Niihara H; Asada H; Kabashima K; Azukizawa H; Hashizume H; Nagao K; Takahashi H; Abe R; Sotozono C; Kurosawa M; Aoyama Y; Chu CY; Chung WH; Shiohara T
    J Dermatol; 2015 Mar; 42(3):276-82. PubMed ID: 25623158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study.
    Kardaun SH; Sekula P; Valeyrie-Allanore L; Liss Y; Chu CY; Creamer D; Sidoroff A; Naldi L; Mockenhaupt M; Roujeau JC;
    Br J Dermatol; 2013 Nov; 169(5):1071-80. PubMed ID: 23855313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug reactions with eosinophilia and systemic symptoms induced by immune checkpoint inhibitors: an international cohort of 13 cases.
    Ingen-Housz-Oro S; Milpied B; Bensaid B; Elshot Y; Brüggen MC; Starace M; Kaffenberger BH; Carrera C; Pham-Ledard A; Freites-Martinez A; Sanchez-Pena P; Lebrun-Vignes B; French LE; Sibaud V
    Melanoma Res; 2023 Apr; 33(2):155-158. PubMed ID: 36749114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary Manifestations of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Systematic Review.
    Taweesedt PT; Nordstrom CW; Stoeckel J; Dumic I
    Biomed Res Int; 2019; 2019():7863815. PubMed ID: 31662996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug reaction with eosinophilia and systemic symptoms (DRESS) induced by phenytoin re-exposure: case report and systematic review.
    Morán-Mariños C; Alva-Diaz C; De la Cruz Ramirez W; Quincho-Lopez A; Mori N; Pacheco-Mendoza J; Romero-Sánchez R
    Acta Clin Belg; 2022 Feb; 77(1):177-185. PubMed ID: 32469684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.